7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Tang L et al. | Effects of different magnitudes of mechanical strain on Osteoblasts in vitro. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16603128 |
| Nakashima A et al. | Osteoprotegerin and bone mineral density in hemodialysis patients. | 2006 | Osteoporos Int | pmid:16604298 |
| Vis M et al. | Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. | 2006 | Ann. Rheum. Dis. | pmid:16606653 |
| Villa I et al. | CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. | 2006 | Am. J. Physiol., Cell Physiol. | pmid:16611736 |
| Barreto FC et al. | Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem. | 2006 | Kidney Int. | pmid:16612334 |
| Swanson C et al. | Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones. | 2006 | Endocrinology | pmid:16614077 |
| Demer LL and Tintut Y | Pitting phosphate transport inhibitors against vascular calcification. | 2006 | Circ. Res. | pmid:16614308 |
| Vik A et al. | Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans. | 2007 | Atherosclerosis | pmid:16620835 |
| Wang Q et al. | [Effect of estrogen on osteoprotegerin, osteoclast differentiation factor and macrophage colony stimulating factor mRNA expressions in ovariectomized rat bone tissue]. | 2006 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:16624776 |
| Dynybil C et al. | [The effect of osteoprotegerin on tendon-bone healing after reconstruction of the anterior cruciate ligament: a histomorphological and radiographical study in the rabbit]. | 2006 Mar-Apr | Z Orthop Ihre Grenzgeb | pmid:16625448 |
| Yamamoto Y et al. | Osteoblasts provide a suitable microenvironment for the action of receptor activator of nuclear factor-kappaB ligand. | 2006 | Endocrinology | pmid:16627581 |
| Kanzaki H et al. | Cyclical tensile force on periodontal ligament cells inhibits osteoclastogenesis through OPG induction. | 2006 | J. Dent. Res. | pmid:16632761 |
| Bersinger NA et al. | PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. | 2006 | Am. J. Obstet. Gynecol. | pmid:16635455 |
| Wang GF et al. | Influence of baicalin on the expression of receptor activator of nuclear factor-kappaB ligand in cultured human periodontal ligament cells. | 2006 | Pharmacology | pmid:16636611 |
| Yang M et al. | The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model. | 2006 | Clin. Cancer Res. | pmid:16638872 |
| Hofbauer LC | Pathophysiology of RANK ligand (RANKL) and osteoprotegerin (OPG). | 2006 | Ann. Endocrinol. (Paris) | pmid:16639364 |
| Matemba SF et al. | Regulation of osteoclastogenesis by gap junction communication. | 2006 | J. Cell. Biochem. | pmid:16639710 |
| Lau YS et al. | Malignant melanoma and bone resorption. | 2006 | Br. J. Cancer | pmid:16641914 |
| Makrygiannakis D et al. | Intraarticular corticosteroids decrease synovial RANKL expression in inflammatory arthritis. | 2006 | Arthritis Rheum. | pmid:16646024 |
| Sylvester FA et al. | Are activated T cells regulators of bone metabolism in children with Crohn disease? | 2006 | J. Pediatr. | pmid:16647405 |
| Coetzee M et al. | Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells. | 2007 | J. Nutr. Biochem. | pmid:16650751 |
| Li Y et al. | Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. | 2006 | Cancer Res. | pmid:16651437 |
| Takayanagi K et al. | Effects of enamel matrix derivative on bone-related mRNA expression in human periodontal ligament cells in vitro. | 2006 | J. Periodontol. | pmid:16671883 |
| Vik A et al. | Serum osteoprotegerin in young survivors of myocardial infarction. | 2006 | Thromb. Haemost. | pmid:16676081 |
| Zhong N et al. | [Relationship between polymorphism of parathyroid hormone and bone mineral density and relevant biochemical indicators in women]. | 2006 | Zhonghua Yi Xue Za Zhi | pmid:16677544 |
| Ohmori R et al. | Association between osteoprotegerin gene polymorphism and coronary artery disease in Japanese men. | 2006 | Atherosclerosis | pmid:16678184 |
| Aoki K et al. | A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. | 2006 | J. Clin. Invest. | pmid:16680194 |
| Anand DV et al. | The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. | 2006 | J. Am. Coll. Cardiol. | pmid:16682312 |
| Mesquita M et al. | Bone cytokines and renal osteodystrophy in peritoneal dialysis patients. | 2005 | Adv Perit Dial | pmid:16686314 |
| Grzegorzewska AE and Mlot M | Using the ratio of serum osteoprotegerin ligand to osteoprotegerin to evaluate renal osteodystrophy in dialysis patients. | 2005 | Adv Perit Dial | pmid:16686316 |
| Hjelmesaeth J et al. | Early posttransplant serum osteoprotegerin levels predict long-term (8-year) patient survival and cardiovascular death in renal transplant patients. | 2006 | J. Am. Soc. Nephrol. | pmid:16687626 |
| Chaki O | [Osteoporosis]. | 2006 | Nippon Rinsho | pmid:16689336 |
| Hess U | [The plasma cell myeloma--molecular pathogenesis and target therapies]. | 2006 | Ther Umsch | pmid:16689452 |
| Burton A | Regulation of RANKL might reduce bone metastases . | 2006 | Lancet Oncol. | pmid:16696160 |
| Wang Q et al. | [Effects of soybean isoflavones on expression levels of osteoprotegerin and osteoprotegerin ligand mRNAs in bone tissues of ovariectomized rats]. | 2006 | Zhong Xi Yi Jie He Xue Bao | pmid:16696921 |
| Liu YH et al. | [Effects of kangfengshi granules on expressions of osteoprotegerin, RANKL and M-CSF in bone tissues of rats with collagen-induced arthritis]. | 2006 | Zhong Xi Yi Jie He Xue Bao | pmid:16696922 |
| Gannagé-Yared MH et al. | Circulating osteoprotegerin is correlated with lipid profile, insulin sensitivity, adiponectin and sex steroids in an ageing male population. | 2006 | Clin. Endocrinol. (Oxf) | pmid:16712667 |
| Rhee EJ et al. | The relationship between four single nucleotide polymorphisms in the promoter region of the osteoprotegerin gene and aortic calcification or coronary artery disease in Koreans. | 2006 | Clin. Endocrinol. (Oxf) | pmid:16712673 |
| Tannehill-Gregg SH et al. | The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. | 2006 | Clin. Exp. Metastasis | pmid:16715352 |
| Thommesen L et al. | Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. | 2006 | J. Cell. Biochem. | pmid:16721825 |
| Liu YH et al. | [Effect of Herba Epimedii flavone on the osteoblasts metabolism in vitro]. | 2006 | Zhongguo Zhong Yao Za Zhi | pmid:16722381 |
| Gori F et al. | Wdr5, a WD-40 protein, regulates osteoblast differentiation during embryonic bone development. | 2006 | Dev. Biol. | pmid:16730692 |
| Geusens PP et al. | The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. | 2006 | Arthritis Rheum. | pmid:16736519 |
| Shin HH et al. | Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells. | 2006 | Bone | pmid:16750437 |
| Zauli G and Secchiero P | The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology. | 2006 | Cytokine Growth Factor Rev. | pmid:16750931 |
| Tat SK et al. | OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation. | 2006 | Bone | pmid:16750945 |
| Sasaki N and Kusano E | [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Measurement and clinical role of OPG]. | 2006 | Clin Calcium | pmid:16751691 |
| Chen G et al. | Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation. | 2006 | Cancer | pmid:16752412 |
| Samadfam R et al. | Implication of prostaglandin receptors in the accumulation of osteoprotegerin in human osteoblast cultures. | 2006 | J. Rheumatol. | pmid:16755666 |
| Nishijima Y et al. | Levels of RANKL and OPG in gingival crevicular fluid during orthodontic tooth movement and effect of compression force on releases from periodontal ligament cells in vitro. | 2006 | Orthod Craniofac Res | pmid:16764680 |
| Chen WF and Wong MS | Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. | 2006 | Br. J. Nutr. | pmid:16768824 |
| Nagae M et al. | Osteoclasts play a part in pain due to the inflammation adjacent to bone. | 2006 | Bone | pmid:16769263 |
| Pérez-MartÃnez FC et al. | Immunohistochemical analysis of low-grade and high-grade prostate carcinoma: relative changes of parathyroid hormone-related protein and its parathyroid hormone 1 receptor, osteoprotegerin and receptor activator of nuclear factor-kB ligand. | 2007 | J. Clin. Pathol. | pmid:16775117 |
| Kacena MA et al. | Megakaryocyte-mediated inhibition of osteoclast development. | 2006 | Bone | pmid:16782418 |
| Messalli EM et al. | Raloxifene therapy interacts with serum osteoprotegerin in postmenopausal women. | 2007 | Maturitas | pmid:16787719 |
| Wakita T et al. | Increase in RANKL: OPG ratio in synovia of patients with temporomandibular joint disorder. | 2006 | J. Dent. Res. | pmid:16798863 |
| Shin JY et al. | Elevated serum osteoprotegerin levels are associated with vascular endothelial dysfunction in type 2 diabetes. | 2006 | Diabetes Care | pmid:16801598 |
| Xiang GD et al. | The relationship between plasma osteoprotegerin and endothelium-dependent arterial dilation in type 2 diabetes. | 2006 | Diabetes | pmid:16804084 |
| Galli C et al. | Osteoprotegerin and receptor activator of nuclear factor-kappa B ligand modulation by enamel matrix derivative in human alveolar osteoblasts. | 2006 | J. Periodontol. | pmid:16805686 |
| Holding CA et al. | The correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implants. | 2006 | Biomaterials | pmid:16806459 |
| Kazama JJ et al. | Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. | 2006 | Ther Apher Dial | pmid:16817791 |
| Granchi D et al. | Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. | 2006 | J Bone Joint Surg Am | pmid:16818976 |
| Lee KS et al. | An antioxidant modulates expression of receptor activator of NF-kappaB in asthma. | 2006 | Exp. Mol. Med. | pmid:16819280 |
| Schenk-Braat EA and Bangma CH | [The search for better markers for prostate cancer than prostate-specific antigen]. | 2006 | Ned Tijdschr Geneeskd | pmid:16821452 |
| Fiore CE et al. | Altered osteoprotegerin/RANKL ratio and low bone mineral density in celiac patients on long-term treatment with gluten-free diet. | 2006 | Horm. Metab. Res. | pmid:16823725 |
| Fábrega E et al. | Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand system in the early post-operative period of liver transplantation. | 2006 May-Jun | Clin Transplant | pmid:16824158 |
| Jeong JH et al. | Expression of RANKL and OPG in middle ear cholesteatoma tissue. | 2006 | Laryngoscope | pmid:16826057 |
| Chung YH et al. | Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. | 2006 | J. Periodont. Res. | pmid:16827722 |
| Lu HK et al. | Identification of the osteoprotegerin/receptor activator of nuclear factor-kappa B ligand system in gingival crevicular fluid and tissue of patients with chronic periodontitis. | 2006 | J. Periodont. Res. | pmid:16827732 |
| Théoleyre S et al. | Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16828054 |
| Valero C et al. | Osteoprotegerin and bone mass in squamous cell head and neck cancer patients. | 2006 | Calcif. Tissue Int. | pmid:16830204 |
| Glass DA and Karsenty G | Canonical Wnt signaling in osteoblasts is required for osteoclast differentiation. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831912 |
| Whyte MP | Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831914 |
| Zallone A | Direct and indirect estrogen actions on osteoblasts and osteoclasts. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831916 |
| Liu XH et al. | Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831922 |
| Matsumoto T and Abe M | Bone destruction in multiple myeloma. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831932 |
| Brunetti G et al. | The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease. | 2006 | Ann. N. Y. Acad. Sci. | pmid:16831934 |
| Bennett BJ et al. | Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. | 2006 | Arterioscler. Thromb. Vasc. Biol. | pmid:16840715 |
| Pepe J et al. | Lumbar bone mineral density as the major factor determining increased prevalence of vertebral fractures in monoclonal gammopathy of undetermined significance. | 2006 | Br. J. Haematol. | pmid:16848794 |
| Kim CH et al. | Oscillatory fluid flow-induced shear stress decreases osteoclastogenesis through RANKL and OPG signaling. | 2006 | Bone | pmid:16860618 |
| Nemoto E et al. | Regulation of cementoblast function by P. gingivalis lipopolysaccharide via TLR2. | 2006 | J. Dent. Res. | pmid:16861291 |
| Yamaguchi M et al. | RANKL increase in compressed periodontal ligament cells from root resorption. | 2006 | J. Dent. Res. | pmid:16861294 |
| Grzegorzewska AE and MÅ‚ot M | Serum markers of bone turnover in dialyzed patients separated according to age. | 2006 | Int Urol Nephrol | pmid:16868703 |
| Robertson KM et al. | Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. | 2006 | J. Bone Miner. Res. | pmid:16869726 |
| Kastritis E et al. | Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support. | 2006 | Clin Lymphoma Myeloma | pmid:16879774 |
| Schwarz C et al. | Diagnosis of renal osteodystrophy. | 2006 | Eur. J. Clin. Invest. | pmid:16884394 |
| Michou L et al. | [Molecular analysis of Paget's disease of bone]. | 2007 Apr-May | Pathol. Biol. | pmid:16884862 |
| Karosi T et al. | Detection of osteoprotegerin and TNF-alpha mRNA in ankylotic Stapes footplates in connection with measles virus positivity. | 2006 | Laryngoscope | pmid:16885748 |
| Franklin M et al. | Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway. | 2006 | Bone | pmid:16890505 |
| Mikosch P et al. | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer. | 2006 | Eur. J. Clin. Invest. | pmid:16893379 |
| Ziółkowska H and Roszkowska-Blaim M | [Osteoprotegerin and calcium-phosphorus metabolism parameters in children with chronic renal failure]. | 2006 | Prz. Lek. | pmid:16898492 |
| Baek KH et al. | Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism. | 2006 | Bone | pmid:16905375 |
| Bernstein CN | Inflammatory bowel diseases as secondary causes of osteoporosis. | 2006 | Curr Osteoporos Rep | pmid:16908001 |
| Mochizuki Y et al. | Correlation between serum osteoprotegerin and biomarkers of bone metabolism during anti-thyroid treatment in patients with Graves' disease. | 2006 | Horm. Res. | pmid:16912510 |
| Roudier MP et al. | Effects of the RANKL inhibitor, osteoprotegerin, on the pain and histopathology of bone cancer in rats. | 2006 | Clin. Exp. Metastasis | pmid:16912914 |
| Kawasaki K et al. | Effects of aging on RANKL and OPG levels in gingival crevicular fluid during orthodontic tooth movement. | 2006 | Orthod Craniofac Res | pmid:16918678 |
| Menezes R et al. | Receptor activator NFkappaB-ligand and osteoprotegerin protein expression in human periapical cysts and granulomas. | 2006 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:16920551 |
| Neumann E | [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?]. | 2006 | Z Rheumatol | pmid:16924451 |
| Rucci N et al. | Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio. | 2007 | J. Cell. Biochem. | pmid:16927271 |
| Wang L et al. | [Inhibitory effect of diacerein on osteoclastic bone destruction and its possible mechanism of action]. | 2006 | Yao Xue Xue Bao | pmid:16927832 |